LIMINATUS PHARMA INC. - CLASS A COMMON STOCK

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

28 Jul 2025 04:30:00 By Nasdaq GlobeNewswire

Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies

25 Jul 2025 05:31:58 By Nasdaq GlobeNewswire

Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy

24 Jul 2025 05:31:00 By Nasdaq GlobeNewswire

Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy

22 Jul 2025 10:30:00 By Nasdaq GlobeNewswire